Evidence map›Paper›PMID 40022165›Full record

ArticleCardiovascular diabetology2025

Relationship between atherogenic index of plasma and length of stay in critically ill patients with atherosclerotic cardiovascular disease: a retrospective cohort study and predictive modeling based on machine learning.

Yu Guo, Fuxu Wang, Shiyin Ma, Zhi Mao, Shuangmei Zhao, Liutao Sui, Chucheng Jiao, Ruogu Lu, Xiaoyan Zhu, Xudong Pan

Abstract read
In one paragraph

Article in Cardiovascular diabetology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yu Guo *Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Fuxu Wang *Department of Critical Care Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China.
Shiyin Ma *Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Zhi MaoDepartment of Critical Care Medicine, The First Medical Center of PLA General Hospital, Beijing, China.
Shuangmei ZhaoDepartment of Critical Care Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China.
Liutao SuiDepartment of Critical Care Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China.
Chucheng JiaoDepartment of Critical Care Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China.
Ruogu LuMedical Innovation Research Department, Chinese PLA General Hospital, Beijing, China. ruogulu2023@163.com.
Xiaoyan ZhuDepartment of Critical Care Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China. zxysdjm@qdu.edu.cn.
Xudong PanDepartment of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, China. drpan022@qdu.edu.cn.

Funding

National Natural Science Foundation of China 82171299
6 · The paper itself

Abstract

backgroundThe atherogenic index of plasma (AIP) is considered an important marker of atherosclerosis and cardiovascular risk. However, its potential role in predicting length of stay (LOS), especially in patients with atherosclerotic cardiovascular disease (ASCVD), remains to be explored. We investigated the effect of AIP on hospital LOS in critically ill ASCVD patients and explored the risk factors affecting LOS in conjunction with machine learning.

methodsUsing data from the Medical Information Mart for Intensive Care (MIMIC)-IV. AIP was calculated as the logarithmic ratio of TG to HDL-C, and patients were stratified into four groups based on AIP values. We investigated the association between AIP and two key clinical outcomes: ICU LOS and total hospital LOS. Multivariate logistic regression models were used to evaluate these associations, while restricted cubic spline (RCS) regressions assessed potential nonlinear relationships. Additionally, machine learning (ML) techniques, including logistic regression (LR), decision tree (DT), random forest (RF), extreme gradient boosting (XGB), and light gradient boosting machine (LGB), were applied, with the Shapley additive explanation (SHAP) method used to determine feature importance.

resultsThe study enrolled a total of 2423 patients with critically ill ASCVD, predominantly male (54.91%), and revealed that higher AIP values were independently associated with longer ICU and hospital stays. Specifically, for each unit increase in AIP, the odds of prolonged ICU and hospital stays were significantly higher, with adjusted odds ratios (OR) of 1.42 (95% CI, 1.11-1.81; P = 0.006) and 1.73 (95% CI, 1.34-2.24; P < 0.001), respectively. The RCS regression demonstrated a linear relationship between increasing AIP and both ICU LOS and hospital LOS. ML models, specifically LGB (ROC:0.740) and LR (ROC:0.832) demonstrated superior predictive accuracy for these endpoints, identifying AIP as a vital component of hospitalization duration.

conclusionAIP is a significant predictor of ICU and hospital LOS in patients with critically ill ASCVD. AIP could serve as an early prognostic tool for guiding clinical decision-making and managing patient outcomes.

Indexed as

AtherosclerosisCholesterol, HDLDecision Support TechniquesLength of StayMachine LearningTriglyceridesAgedBiomarkersCritical IllnessDatabases, FactualFemaleHumansIntensive Care UnitsMaleMiddle AgedPredictive Value of TestsBiomarkersCholesterol, HDLTriglyceridesAIPAtherosclerotic cardiovascular diseaseLOSMachine learningMIMIC-IV

Identifiers

PMID40022165
PMCPMC11871731

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.